Literature DB >> 2672343

Corticosteroids in rheumatoid arthritis.

M M Weiss1.   

Abstract

This report has presented evidence to support a disease-modifying role for corticosteroids in rheumatoid arthritis. It would appear that the efficacy of these agents in retarding the destructive course of rheumatoid disease has been substantially underestimated. Consideration for more liberal use of corticosteroids in the management of rheumatoid arthritis is warranted. Further study on new approaches to corticosteroid delivery is proposed.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2672343     DOI： 10.1016/0049-0172(89)90083-8

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN： 0049-0172            Impact factor:   5.532


  11 in total

Review 1.  Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?

Authors:  T Pullar
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

2.  [Not Available].

Authors:  C Grondin
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

Review 3.  Management issues with elderly-onset rheumatoid arthritis: an update.

Authors:  Ignazio Olivieri; Carlo Palazzi; Giovanni Peruz; Angela Padula
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis.

Authors:  P C Gøtzsche; H K Johansen
Journal:  BMJ       Date:  1998-03-14

Review 5.  Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.

Authors:  P C Gotzsche; H K Johansen
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 6.  Rheumatoid arthritis in the aged. Incidence and optimal management.

Authors:  G Nesher; T L Moore
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

7.  Changes in calcium and bone metabolism during treatment with low dose prednisone in young, healthy, male volunteers.

Authors:  W F Lems; J W Jacobs; H J Van Rijn; J W Bijlsma
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

Review 8.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

Review 9.  Effects of glucocorticoids on radiological progression in rheumatoid arthritis.

Authors:  J R Kirwan; J W J Bijlsma; M Boers; B J Shea
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

10.  Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial.

Authors:  T Pincus; C J Swearingen; G Luta; T Sokka
Journal:  Ann Rheum Dis       Date:  2008-12-15       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.